SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why? -- Ignore unavailable to you. Want to Upgrade?


To: Fred Ayres who wrote (310)12/5/1997 8:07:00 AM
From: Douglas  Read Replies (1) | Respond to of 455
 
Fred,

I have not heard anything concerning UFEM and additional financing. I did some research into UFEM and was surprised at their cash burn rate. Extremely high! This fact and their sales numbers aren't encouraging.

I spoke to Procept about their financing plans. Everything is still working. I expect a bounce in Procept's stock price when they make an announcement.

Doug.